Content about Book:Allergies

April 15, 2014

Merck announced that the Food and Drug Administration has approved Grastek (Timothy grass pollen allergen extract) tablet for sublingual use.

WHITEHOUSE STATION, N.J. — Merck announced that the Food and Drug Administration has approved Grastek (Timothy grass pollen allergen extract) tablet for sublingual use. The drug is an allergen extract used for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis. It is approved for use in persons ages 5 years through 65 years of age.

April 2, 2014

Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.

LENOIR, N.C. — Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.

February 5, 2013

WebMD Health launched the WebMD Allergy app for the iPhone, a mobile resource that empowers consumers to take control of their allergies.

NEW YORK — WebMD Health Corp. on Tuesday launched the WebMD Allergy app for the iPhone, a mobile resource that empowers consumers to take control of their allergies. 

"The WebMD Allergy app provides consumers with accurate and personalized weather-related allergy information to help them proactively manage their allergy conditions," stated Michael Smith, WebMD chief medical editor. "WebMD's trusted allergy information is delivered through an innovative mobile app to help consumers be better prepared to face the day."